Cargando…
Early- and late anthracycline-induced cardiac dysfunction: echocardiographic characterization and response to heart failure therapy
BACKGROUND: Anthracycline-induced cardiac dysfunction (ACD) is a notorious side effect of anticancer treatment. It has been described as a phenomenon of a continuous progressive decline of cardiac function, eventually leading to dilated cardiomyopathy (DCM). This progressive nature suggests that pat...
Autores principales: | Kamphuis, Janine A. M., Linschoten, Marijke, Cramer, Maarten J., Doevendans, Pieter A., Asselbergs, Folkert W., Teske, Arco J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7557080/ https://www.ncbi.nlm.nih.gov/pubmed/33072403 http://dx.doi.org/10.1186/s40959-020-00079-3 |
Ejemplares similares
-
Cancer Therapy-Related Cardiac Dysfunction of Nonanthracycline Chemotherapeutics: What Is the Evidence?
por: Kamphuis, Janine A.M., et al.
Publicado: (2019) -
Optimal echocardiographic assessment of myocardial dysfunction for arrhythmic risk stratification in phospholamban mutation carriers( )
por: Taha, Karim, et al.
Publicado: (2021) -
Echocardiographic quantification of myocardial function using tissue deformation imaging, a guide to image acquisition and analysis using tissue Doppler and speckle tracking
por: Teske, Arco J, et al.
Publicado: (2007) -
LVEF by Multigated Acquisition Scan Compared to Other Imaging Modalities in Cardio-Oncology: a Systematic Review
por: Printezi, Markella I., et al.
Publicado: (2022) -
Cardio-oncology: an overview on outpatient management and future developments
por: Teske, A. J., et al.
Publicado: (2018)